Page 432 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )
P. 432

Case studies                                                                                                   NOTE:


                 Analyze the patient history, clinical signs and symptoms, and labo-                                          ■   indicates MLT and MLS core content

                   ratory data for the stated case studies; answer the related critical                                         indicates MLT (optional) and MLS advanced content

                   thinking questions; and conclude the most likely diagnosis.











               LEUKEMIAS VERSUS LYMPHOMAS                                                                                     NOTE: This is a good time to review the de  nitions of the Key

                                                                                                                              Terms in the Glossary and   ash cards on                                         .

               T e ter   ly  phoproli er  tive   isor  er inclu  es the v  rious
                or  s o  leukemias   n   lymphomas th  t   re o  ly  phoreticu-


               l  r origin. Ly  phoi   neopl  s   cl  ssif c  tions   re b  se   on
               the   istribution o    ise  se   s leuke  i   or ly  pho    . T e                                           CHRONIC LYMPHOCYTOSIS


               neopl  stic cells o  leuke  i     n   ly  pho     h  ve   n inti    te
               rel  tionship. Frequently, the neopl  stic cells o  these two   is-                                         Tere   re v  rious con  itions th  t pro  uce    chronic ly  -


               or  ers   re i  entic  l (    ble 22.1).                                                                    phocytosis  (Box  22.1).  T ese  con  itions  c  n  be  benign
                    Leuke  i  s  represent  overproli er  tion  or    ccu  ul  tion                                        or     lign  nt   n   involve either    or B ly  phocytes. T e


               o  he    topoietic cells in the circul  ting bloo     n  /or bone                                              lign  nt con  itions th  t   ust be consi  ere   in the   i -
                   rrow.  During  the  progression  o     ise  se  in  so  e  ly  -                                         erenti  l    i  gnosis  o   chronic  lymphocytic  leukemia (CLL)


               pho    s, the     lign  nt cells     y spill into the bloo   circu-                                           re     lign  nt B-   n     -cell   isor  ers   s well   s    spillover
               l  tion. T is spillover     y pro  uce    leuke  ic ph  se o  the                                           leuke  ic  ph  se  o   so  e  c  ses  o   non-Hodgkin  lymphoma


                 ise  se.   r  nsitions to    leuke  ic ph  se   re r  re in   isor  ers                                   (NHLs).
               such   s Hodgkin disease but   re not unco    on in the well-


                 i  erenti  te   non-Ho  gkin ly  phocytic ly  pho    s. In the                                            Chronic Lymphocytic Leukemia (CLL)/ Small
               l  bor  tory, bone     rrow   n   peripher  l bloo   speci  ens   re                                        Lymphocytic Lymphoma (SLL)


               stu  ie   by   icroscopic ex    in  tion,   ow cyto  etry, cyto-                                            Chronic leuke  i  s   re gener  lly ch  r  cterize   by the pres-
               che  ic  l st  ining,   n   chro  oso  e   n     olecul  r   n  lysis.                                      ence o  leukocytosis with   n incre  se   nu  ber o      ture


               T e  requency o  ex    in  tion o  bone     rrow   n   periph-                                              ly  phocytes, ly  phocytosis, on    peripher  l bloo   f l  .
               er  l bloo   involve  ent   epen  s on the ly  pho     subtype.                                             For  ex    ple,      lign  nt  ly  phoproli er  tive    isor  ers


                    Ly  pho    s   re    heterogeneous group o  closely rel  te                                            (    ble  22.2)    re  ch  r  cterize    by    n    ccu  ul  tion  o
                 isor  ers th  t   re ch  r  cterize   by the overproli er  tion o                                         ly  phocytes.


               one or   ore types o  cells o  the ly  phoi   syste   such   s                                                   Both CLL   n   SLL   re neopl  s  s co  pose   o  s    ll B
               ly  phoreticul  r  ste    cells,  ly  phocytes,  reticulu    cells,                                         ly  phocytes in the peripher  l bloo  , bone     rrow, spleen,


                 n   histiocytes. Ly  pho    s   re     lign  nt neopl  s  s th  t                                          n   ly  ph no  es,   ixe   with proly  phocytes  n   p r  -
               involve ly  phoi   org  ns or tissues, inclu  ing ly  ph no  es.                                            i    unobl  sts  or  ing proli er  tion centers in tissue inf l-


               Stu  y o     ly  phoi   tissue     ss or ly  ph no  e is per or  e                                          tr  tes.  In  contr  st  to  CLL,  SLL  is  use     or  nonleuke  ic
               by obt  ining    speci  en  ro      biopsy or f ne-nee  le   spi-                                           p  tients with the tissue   orphology   n    i    unopheno-


               r  te  o           ss.  An  lysis  o       speci  en  is  by    icroscopic                                  type o  CLL.
               ex    in  tion,    ow  cyto  etry,  cytoche  ic  l  st  ining,    n


               chro  oso  e   n     olecul  r   n  lysis.





                                            Relationship of Leukemias and                                                       BOX  22.1
                    TABLE        22.1
                                            Lymphomas


                                                                                                                              Examples of World Health Organization of
                   Leukemia Type                              Solid Tumor Counterpart
                                                                                                                              Mature B-Cell Neoplasms

                   Stem cell leukemia                         Lymphoma, undifferentiated
                                                                                                                              Chronic ly  phocytic leuke  i  /s    ll ly  phocytic leuke  i

                   Acute lymphoblastic                        Lymphoma, poorly leukemia                                       B-cell proly  phocytic leuke  i

                                                                differentiated; lymphocytic                                   H  iry cell leuke  i

                                                                                                                              Pl  s     cell   yelo
                   Chronic lymphocytic                        Lymphoma, well leukemia

                                                                differentiated; lymphocytic                                   Monoclon  l g      op  thy o  un  eter  ine   signif c  nce
                                                                                                                                    (MGUS)

                   Monocytic leukemia                         Reticulum cell sarcoma                                          Pri    ry     yloi  osis

                                                                                                                              He  vy ch  in   ise  ses
                   Acute myelogenous                          Chloroma granulocytic leukemia
                                                                                                                              Burkitt ly  pho    /leuke  i
                   Plasma cell leukemia                       Myeloma
   427   428   429   430   431   432   433   434   435   436   437